CAPHOSOL shown to benefit cancer patients undergoing chemotherapy and radiation therapy
New data show that CAPHOSOL, an advanced electrolyte solution, results in low rates of oral mucositis and pain in patients with head and neck (HN) cancer who are undergoing chemotherapy and radiation therapy.
The data, which were presented at the Advanced Practice Nursing Conference of the Oncology Nursing Society (ONS), demonstrate that use of CAPHOSOL from the initiation of cancer treatment results in a low incidence of oral mucositis (OM) and is associated with high levels of patient and physician satisfaction and medication compliance.
Read the rest of this entry »